Maximus (NYSE:MMS) Trading Down 11.6% – Should You Sell?

Shares of Maximus, Inc. (NYSE:MMS) dropped 11.6% during trading on Thursday . The stock traded as low as $54.16 and last traded at $55.85. Approximately 242,936 shares were traded during mid-day trading, a decline of 66% from the average daily volume of 717,651 shares. The stock had previously closed at $63.15.

Analysts Set New Price Targets

Several equities analysts have recently commented on the stock. Wall Street Zen upgraded shares of Maximus from a “hold” rating to a “buy” rating in a research report on Saturday, June 6th. Zacks Research lowered shares of Maximus from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 27th. Finally, Weiss Ratings cut shares of Maximus from a “hold (c)” rating to a “hold (c-)” rating in a research note on Wednesday, May 20th. Two investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, Maximus currently has a consensus rating of “Hold”.

Maximus Trading Down 9.5%

The company has a current ratio of 2.21, a quick ratio of 2.21 and a debt-to-equity ratio of 0.87. The firm has a market capitalization of $3.00 billion, a P/E ratio of 8.51 and a beta of 0.59. The firm has a 50-day moving average of $58.77 and a two-hundred day moving average of $67.80.

Maximus (NYSE:MMS) last released its earnings results on Thursday, August 6th. The health services provider reported $2.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.21 by $0.01. The firm had revenue of $1.28 billion for the quarter, compared to analysts’ expectations of $1.33 billion. Maximus had a return on equity of 25.10% and a net margin of 7.02%.The business’s revenue for the quarter was down 5.1% on a year-over-year basis. During the same quarter in the previous year, the business posted $2.16 earnings per share. Maximus has set its FY 2026 guidance at 7.900-8.200 EPS. On average, analysts anticipate that Maximus, Inc. will post 8.43 EPS for the current year.

Maximus Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, August 31st. Investors of record on Friday, August 14th will be issued a dividend of $0.33 per share. The ex-dividend date of this dividend is Friday, August 14th. This represents a $1.32 annualized dividend and a dividend yield of 2.3%. Maximus’s payout ratio is 19.76%.

Hedge Funds Weigh In On Maximus

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. GSA Capital Partners LLP acquired a new stake in Maximus in the second quarter valued at approximately $693,000. Oppenheimer Asset Management Inc. acquired a new position in shares of Maximus during the second quarter worth $981,000. Walleye Capital LLC bought a new position in shares of Maximus in the 2nd quarter valued at $20,645,000. Reinhart Partners LLC. lifted its stake in shares of Maximus by 131.8% in the 2nd quarter. Reinhart Partners LLC. now owns 1,982,415 shares of the health services provider’s stock valued at $106,575,000 after acquiring an additional 1,127,346 shares during the last quarter. Finally, Assenagon Asset Management S.A. acquired a new stake in shares of Maximus during the 2nd quarter valued at $1,719,000. Institutional investors own 97.21% of the company’s stock.

Maximus Company Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.